Energy metabolism in cachexia.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
04 2019
Historique:
received: 17 10 2018
revised: 11 01 2019
accepted: 05 02 2019
pubmed: 21 3 2019
medline: 1 5 2020
entrez: 21 3 2019
Statut: ppublish

Résumé

Cachexia is a wasting disorder that accompanies many chronic diseases including cancer and results from an imbalance of energy requirements and energy uptake. In cancer cachexia, tumor-secreted factors and/or tumor-host interactions cause this imbalance, leading to loss of adipose tissue and skeletal and cardiac muscle, which weakens the body. In this review, we discuss how energy enters the body and is utilized by the different organs, including the gut, liver, adipose tissue, and muscle, and how these organs contribute to the energy wasting observed in cachexia. We also discuss futile cycles both between the organs and within the cells, which are often used to fine-tune energy supply under physiologic conditions. Ultimately, understanding the complex interplay of pathologic energy-wasting circuits in cachexia can bring us closer to identifying effective treatment strategies for this devastating wasting disease.

Identifiants

pubmed: 30890538
pii: embr.201847258
doi: 10.15252/embr.201847258
pmc: PMC6446208
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© 2019 The Authors.

Références

J Cachexia Sarcopenia Muscle. 2017 Feb;8(1):122-130
pubmed: 27897403
Physiol Rev. 2009 Apr;89(2):381-410
pubmed: 19342610
J Biol Chem. 2005 Jan 28;280(4):2847-56
pubmed: 15531760
Age Ageing. 1996 May;25(3):221-3
pubmed: 8670557
Biochim Biophys Acta. 2013 May;1831(5):950-9
pubmed: 23454374
Cancer Res. 2011 Mar 1;71(5):1710-20
pubmed: 21163868
Metabolism. 2000 Jul;49(7):931-6
pubmed: 10910006
Br J Cancer. 2002 Feb 1;86(3):424-8
pubmed: 11875710
Curr Pharm Des. 2013;19(10):1956-64
pubmed: 23305268
Clin Physiol. 1989 Oct;9(5):427-39
pubmed: 2582730
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):824-838
pubmed: 28730707
Nature. 2014 Sep 4;513(7516):100-4
pubmed: 25043053
Proc Natl Acad Sci U S A. 2001 Dec 4;98(25):14440-5
pubmed: 11717410
J Physiol. 2005 Jul 15;566(Pt 2):575-86
pubmed: 15878950
PLoS One. 2011;6(6):e21006
pubmed: 21701596
Front Physiol. 2017 Mar 01;8:119
pubmed: 28298897
PLoS One. 2012;7(6):e37971
pubmed: 22761662
Oncol Rev. 2012 Jun 12;6(1):e11
pubmed: 25992201
Circulation. 2001 Sep 18;104(12):1430-5
pubmed: 11560861
Cell Metab. 2009 Dec;10(6):507-15
pubmed: 19945408
Diabetes. 2002 May;51(5):1319-36
pubmed: 11978627
Nat Med. 2016 Oct;22(10):1120-1130
pubmed: 27571348
Mol Metab. 2016 May 14;5(7):480-490
pubmed: 27408774
Mol Cell Biochem. 1996 Dec 6;165(1):17-23
pubmed: 8974077
Nature. 1999 Dec 9;402(6762):656-60
pubmed: 10604470
Science. 2000 Sep 29;289(5488):2363-6
pubmed: 11009425
Gastroenterology. 2012 Oct;143(4):913-6.e7
pubmed: 22728514
Lipids Health Dis. 2016 Jun 18;15:108
pubmed: 27317359
Br J Cancer. 2009 Jan 13;100(1):63-9
pubmed: 19127266
J Cachexia Sarcopenia Muscle. 2017 Oct;8(5):778-788
pubmed: 28614627
Nature. 2006 Jan 26;439(7075):484-9
pubmed: 16400329
Br J Cancer. 2010 May 11;102(10):1541-8
pubmed: 20407445
Biochim Biophys Acta. 2011 Dec;1812(12):1601-6
pubmed: 21914473
Nat Med. 2017 Dec;23(12):1454-1465
pubmed: 29131158
J Cancer Res Clin Oncol. 1986;111(1):82-5
pubmed: 3949854
Sci Rep. 2015 Jun 30;5:11737
pubmed: 26122953
FASEB J. 2004 Jan;18(1):39-51
pubmed: 14718385
EMBO J. 2017 Jul 14;36(14):1999-2017
pubmed: 28623240
Front Neurosci. 2015 Jun 03;9:199
pubmed: 26089773
Nat Genet. 2013 Nov;45(11):1309-18
pubmed: 24076600
FASEB J. 2018 Sep;32(9):4727-4743
pubmed: 29570397
Am J Pathol. 2013 Apr;182(4):1367-78
pubmed: 23395093
Oncotarget. 2017 Aug 24;8(42):72872-72885
pubmed: 29069832
PLoS One. 2014 Jan 03;9(1):e83618
pubmed: 24404136
Hepatology. 2017 Dec;66(6):2055-2065
pubmed: 28777879
JPEN J Parenter Enteral Nutr. 2000 Nov-Dec;24(6):317-22
pubmed: 11071589
Cancer Res. 2007 Jun 1;67(11):5531-7
pubmed: 17545636
Proc Natl Acad Sci U S A. 2013 Nov 5;110(45):18162-7
pubmed: 24145431
Cell Metab. 2012 Aug 8;16(2):153-66
pubmed: 22795476
Cancer Res. 1984 Dec;44(12 Pt 1):5910-3
pubmed: 6388829
Oncotarget. 2018 Apr 6;9(26):18224-18238
pubmed: 29719601
Hum Gene Ther. 2011 Mar;22(3):313-24
pubmed: 21126200
Crit Rev Oncol Hematol. 2011 Oct;80(1):114-44
pubmed: 21216616
Am J Physiol Endocrinol Metab. 2012 Oct 15;303(8):E983-93
pubmed: 22895779
Diabetes. 2009 Jul;58(7):1509-17
pubmed: 19366864
Clin Cancer Res. 2003 Feb;9(2):774-8
pubmed: 12576449
PLoS One. 2015 Mar 19;10(3):e0119888
pubmed: 25789991
Cell Metab. 2014 Sep 2;20(3):433-47
pubmed: 25043816
Curr Opin Clin Nutr Metab Care. 2008 Sep;11(5):632-9
pubmed: 18685461
Pancreas. 2012 Mar;41(2):230-2
pubmed: 21926936
Biochem Biophys Res Commun. 2018 Nov 17;506(1):122-129
pubmed: 30340833
J Cachexia Sarcopenia Muscle. 2015 Jun;6(2):132-43
pubmed: 26136189
J Cachexia Sarcopenia Muscle. 2015 Mar;6(1):53-61
pubmed: 26136412
Lipids Health Dis. 2018 Jan 16;17(1):14
pubmed: 29338749
FEBS J. 2012 Sep;279(17):3192-202
pubmed: 22776428
Braz J Med Biol Res. 1998 Oct;31(10):1345-8
pubmed: 9876308
Nutr Rev. 2016 Nov;74(11):659-669
pubmed: 27753623
Br J Cancer. 1992 Jul;66(1):57-61
pubmed: 1637677
J Nucl Med. 2013 Apr;54(4):523-31
pubmed: 23362317
Clin Endocrinol (Oxf). 2011 Jan;74(1):67-72
pubmed: 21039722
Cytokine. 1993 Sep;5(5):436-47
pubmed: 8142598
Cell Metab. 2007 Dec;6(6):472-83
pubmed: 18054316
Mol Metab. 2015 Nov 26;5(2):67-78
pubmed: 26909315
Clin Sci (Lond). 1997 Apr;92(4):385-9
pubmed: 9176038
Biochim Biophys Acta. 2014 May;1842(5):726-33
pubmed: 24534708
Theor Biol Med Model. 2015 Sep 15;12:17
pubmed: 26370269
Nat Rev Dis Primers. 2018 Jan 18;4:17105
pubmed: 29345251
Nat Med. 2016 Jun;22(6):666-71
pubmed: 27135739
Lipids Health Dis. 2011 Dec 20;10:238
pubmed: 22182284
Appetite. 2015 Aug;91:298-301
pubmed: 25912786
Trends Endocrinol Metab. 2013 Dec;24(12):635-43
pubmed: 24182456
Lancet Oncol. 2016 Apr;17(4):519-531
pubmed: 26906526
EMBO Mol Med. 2013 Feb;5(2):294-308
pubmed: 23307490
J Clin Endocrinol Metab. 2004 Jun;89(6):2832-6
pubmed: 15181065
Cell Metab. 2007 Dec;6(6):458-71
pubmed: 18054315
Mol Metab. 2015 Mar 21;4(6):437-60
pubmed: 26042199
J Biol Chem. 1991 Feb 15;266(5):2978-82
pubmed: 1993670
Int J Clin Oncol. 2009 Aug;14(4):315-20
pubmed: 19705241
Am J Physiol Endocrinol Metab. 2001 Aug;281(2):E289-97
pubmed: 11440905
PLoS One. 2012;7(9):e46589
pubmed: 23029553
J Cachexia Sarcopenia Muscle. 2015 Dec;6(4):287-302
pubmed: 26675762
PLoS One. 2015 Dec 28;10(12):e0145583
pubmed: 26709824
Br J Cancer. 1991 May;63(5):719-22
pubmed: 1674876
FEBS Lett. 1989 Jan 2;242(2):237-9
pubmed: 2464504
Neuropharmacology. 2018 Mar 15;131:282-290
pubmed: 29247677
World J Surg. 1999 Jun;23(6):584-8
pubmed: 10227928
Anticancer Res. 1994 Mar-Apr;14(2B):647-50
pubmed: 8010722
Br J Cancer. 2011 Feb 1;104(3):441-7
pubmed: 21245862
Cell. 2015 Oct 22;163(3):643-55
pubmed: 26496606
Biosci Rep. 1981 Jun;1(6):509-17
pubmed: 7295902
Horm Cancer. 2014 Feb;5(1):33-41
pubmed: 24101584
Science. 2001 Nov 23;294(5547):1704-8
pubmed: 11679633
Semin Cell Dev Biol. 2016 Jun;54:11-9
pubmed: 26564688
Proc Natl Acad Sci U S A. 2013 Dec 10;110(50):20176-81
pubmed: 24248371
J Cancer Res Clin Oncol. 2013 Jul;139(7):1105-15
pubmed: 23535871
Shock. 2017 Jan;47(1):33-39
pubmed: 27648696
Endocrinology. 2010 Feb;151(2):683-94
pubmed: 19996183
J Am Med Dir Assoc. 2016 Sep 1;17(9):789-96
pubmed: 27324808
J Natl Cancer Inst. 2012 Mar 7;104(5):371-85
pubmed: 22345712
Cell. 1987 Aug 14;50(4):555-63
pubmed: 3607879
Hepatology. 2008 Sep;48(3):782-91
pubmed: 18712775
Dig Dis Sci. 2007 Mar;52(3):803-9
pubmed: 17245626
Hepatogastroenterology. 2012 Oct;59(119):2348-51
pubmed: 22709824
Cancer Res. 2012 Sep 1;72(17):4372-82
pubmed: 22719069
Metabolism. 1994 Apr;43(4):481-6
pubmed: 8159108
Gastroenterology. 2008 May;134(6):1729-40
pubmed: 18471550
Pediatr Blood Cancer. 2017 Aug;64(8):
pubmed: 28074537
Nature. 2000 Oct 19;407(6806):908-13
pubmed: 11057670
Nature. 2013 Dec 19;504(7480):437-40
pubmed: 24226772
Lancet. 2008 Oct 11;372(9646):1342-53
pubmed: 18929906
Age Ageing. 1996 Mar;25(2):144-9
pubmed: 8670544
J Cachexia Sarcopenia Muscle. 2012 Mar;3(1):31-6
pubmed: 22450540
Am J Clin Nutr. 2005 Oct;82(4):801-5
pubmed: 16210709
ISME J. 2016 Jun;10(6):1456-70
pubmed: 26613342
Sci Transl Med. 2017 Nov 29;9(418):
pubmed: 29187643
J Cachexia Sarcopenia Muscle. 2014 Dec;5(4):279-86
pubmed: 25118829
Biochim Biophys Acta. 2015 Nov;1851(11):1490-500
pubmed: 26327596
Science. 2011 Jul 8;333(6039):233-8
pubmed: 21680814
Tumour Biol. 2017 Mar;39(3):1010428317695960
pubmed: 28345452
PLoS One. 2017 Mar 1;12(3):e0173113
pubmed: 28249026
Eur J Biochem. 1995 Jan 15;227(1-2):352-8
pubmed: 7851408
J Cell Biol. 2010 Dec 27;191(7):1395-411
pubmed: 21187332
Diabetes Obes Metab. 2013 May;15(5):474-7
pubmed: 23181598
Annu Rev Nutr. 1999;19:379-406
pubmed: 10448530
Cancer Res. 1998 Jun 1;58(11):2353-8
pubmed: 9622074
Ann Surg. 1994 Apr;219(4):325-31
pubmed: 7512810
J Clin Invest. 1994 Jun;93(6):2379-86
pubmed: 8200971
Am J Clin Nutr. 2013 Dec;98(6):1485-92
pubmed: 24108784
J Genet. 2011 Apr;90(1):165-77
pubmed: 21677406

Auteurs

Maria Rohm (M)

Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.
Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, Heidelberg, Germany.

Anja Zeigerer (A)

Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.
Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, Heidelberg, Germany.

Juliano Machado (J)

Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany.
Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, Heidelberg, Germany.

Stephan Herzig (S)

Institute for Diabetes and Cancer (IDC), Helmholtz Center Munich, Neuherberg, Germany stephan.herzig@helmholtz-muenchen.de.
Joint Heidelberg-IDC Translational Diabetes Program, Inner Medicine I, Heidelberg University Hospital, Heidelberg, Germany.
Chair Molecular Metabolic Control, Technical University Munich, Munich, Germany.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH